Avidity Partners Management LP - Significant Ownership

Signature - Title
By: Avidity Partners Management (GP) LLC, its general partner, By: /s/ Michael Gregory - Michael Gregory/Managing Member
Location
Dallas, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Avidity Partners Management LP.

Significant Ownership of Avidity Partners Management LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DNTH Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value 9.9% $52.7M 3.38M Avidity Partners Management LP Mar 17, 2025
CNTX Context Therapeutics Inc. Common Stock, par value $0.001 per share 9.9% $7.94M $1.17M 9.13M +17.4% Avidity Partners Management LP Jun 30, 2025
SCYX SCYNEXIS INC Common Stock, par value $0.001 per share 9.9% $3.62M 4.21M Avidity Master Fund LP Dec 31, 2024
SYRS Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value 7.6% $41K 2.05M Avidity Partners Management LP Dec 31, 2024
KZR Kezar Life Sciences, Inc. Common Stock, par value $0.001 per share 6.9% $387K 503K Avidity Partners Management LP Dec 31, 2024
IMUX IMMUNIC, INC. Common Stock, $0.0001 par value 5.9% $4.77M -$361K 5.62M -7.04% Avidity Partners Management LP Jun 30, 2025
CATX Perspective Therapeutics, Inc. Common Stock, $0.001 par value 4.2% $5.28M 2.84M Avidity Partners Management LP Dec 31, 2024

Schedules 13D/G Reported by Avidity Partners Management LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.